Key Segmentation:
By Type
-
PET Injectors
-
PET and SPECT Injectors
-
Theranostic Injectors
By Operation Mode
-
Automated
-
Manual
By Clinical Area
-
Oncology
-
Cardiology
-
Neurology
-
Others
By End User
-
Hospitals and Clinics
-
Diagnostic Imaging Centers
-
Research Institutions
-
Nuclear Pharmacies
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Bayer, Comecer, Tema Sinergie, Lemer Pax, and Sumitomo Heavy Industries.
The market was valued at USD 34.60 Million in 2025 and is projected to reach USD 71.98 Million by 2035.
The market is expected to register a CAGR of 7.60% from 2026 to 2035.
North America led the market with a 38.40% share in 2025.
Asia Pacific is expected to grow the fastest, at a CAGR of 10.40% from 2026 to 2035.
PET injectors led the type segment with a 72.40% share in 2025, and automated injectors led the operation mode segment.